Suchergebnisse - "Spiekermann, Karsten"

PubPharm (8)

1

Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia

enthalten in: Blood | 2016

von Metzeler, K. | Herold, T. | Rothenberg-Thurley, M. | +23

2

Improved outcome of adult Burkitt lymphoma/leukemia with rituximab and chemotherapy : report of a large prospective multicenter trial

enthalten in: Blood | 2014

von Hoelzer, D. | Walewski, J. | Döhner, H. | +22

3

Isolated trisomy 13 defines a homogeneous AML subgroup with high frequency of mutations in spliceosome genes and poor prognosis

enthalten in: Blood | 2014

von Herold, T. | Metzeler, K. | Vosberg, S. | +25

4

Exome sequencing identifies recurring FLT3 N676K mutations in core-binding factor leukemia

enthalten in: Blood | 2013

von Opatz, S. | Polzer, H. | Herold, T. | +20

5

Inactivation of TP53 correlates with disease progression and low miR-34a expression in previously treated chronic lymphocytic leukemia patients

enthalten in: Blood | 2013

von Dufour, A. | Palermo, G. | Zellmeier, E. | +24

6

GATA2 zinc finger 1 mutations associated with biallelic CEBPA mutations define a unique genetic entity of acute myeloid leukemia

enthalten in: Blood | 2012

von Greif, P. | Dufour, A. | Konstandin, N. | +26

7

The FLT3ITD mRNA level has a high prognostic impact in NPM1 mutated, but not in NPM1 unmutated, AML with a normal karyotype

enthalten in: Blood | 2012

von Schneider, F. | Hoster, E. | Unterhalt, M. | +17

8

An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia

enthalten in: Blood | 2008

von Metzeler, K. | Hummel, M. | Bloomfield, C. | +19

1
[1]